Abstract:Microglia activation is observed in various neurodegenerative diseases. Recent advances in single-cell technologies have revealed that these reactive microglia were with high spatial and temporal heterogeneity. Some identified microglia in specific states correlate with pathological hallmarks and are associated with specific functions. Microglia both exert protective function by phagocytosing and clearing pathological protein aggregates and play detrimental roles due to excessive uptake of protein aggregates, which would lead to microglial phagocytic ability impairment, neuroinflammation, and eventually neurodegeneration. In addition, peripheral immune cells infiltration shapes microglia into a pro-inflammatory phenotype and accelerates disease progression. Microglia also act as a mobile vehicle to propagate protein aggregates. Extracellular vesicles released from microglia and autophagy impairment in microglia all contribute to pathological progression and neurodegeneration. Thus, enhancing microglial phagocytosis, reducing microglial-mediated neuroinflammation, inhibiting microglial exosome synthesis and secretion, and promoting microglial conversion into a protective phenotype are considered to be promising strategies for the therapy of neurodegenerative diseases. Here we comprehensively review the biology of microglia and the roles of microglia in neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, multiple system atrophy, amyotrophic lateral sclerosis, frontotemporal dementia, progressive supranuclear palsy, corticobasal degeneration, dementia with Lewy bodies and Huntington's disease. We also summarize the possible microglia-targeted interventions and treatments against neurodegenerative diseases with preclinical and clinical evidence in cell experiments, animal studies, and clinical trials.

Modulating the polarization phenotype of microglia - A valuable strategy for central nervous system diseases

Polarization of Microglia to the M2 Phenotype in A Peroxisome Proliferator-Activated Receptor Gamma-Dependent Manner Attenuates Axonal Injury Induced by Traumatic Brain Injury in Mice

Microglia Polarization From M1 to M2 in Neurodegenerative Diseases

The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer’s disease

The Polarization States of Microglia in Tbi: A New Paradigm for Pharmacological Intervention

Microglial polarization: novel therapeutic mechanism against Alzheimer’s disease

LncRNA, an Emerging Approach for Neurological Diseases Treatment by Regulating Microglia Polarization

Microglial Phenotypic Transition: Signaling Pathways and Influencing Modulators Involved in Regulation in Central Nervous System Diseases

Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target

Role of Microglia in Neurological Disorders and Their Potentials As a Therapeutic Target

Regulation of microglia polarization after cerebral ischemia

Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis

Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis

New insight on microglia activation in neurodegenerative diseases and therapeutics

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

Modulators of microglial activation and polarization after intracerebral haemorrhage

Microglial and macrophage polarization—new prospects for brain repair

Cell polarization in ischemic stroke: molecular mechanisms and advances

The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis

Metabolic reprogramming and polarization of microglia in Parkinson's disease: Role of inflammasome and iron

Microglia Pyroptosis: A Candidate Target for Neurological Diseases Treatment